Nondrug therapies that might have been dismissed 30 years ago are now the sorts of treatments physicians are turning to instead of overused treatments like surgical procedures, opioids, and injections, said Daniel Clauw, MD, professor of anesthesiology, medicine (rheumatology), and psychiatry; director of translational research; and director of the Center for Chronic Pain and Fatigue Research.
Nondrug therapies that might have been dismissed 30 years ago are now the sorts of treatments physicians are turning to instead of overused treatments like surgical procedures, opioids, and injections, said Daniel Clauw, MD, professor of anesthesiology, medicine (rheumatology), and psychiatry; director of translational research; and director of the Center for Chronic Pain and Fatigue Research.
Transcript
How has pain management for patients with fibromyalgia evolved? Are opioids still beneficial for these patients, since they experience chronic pain, or are we starting to find alternatives so we can taper these patients off opioids?
So, in the last 20 years or so I think physicians have understood that fibromyalgia is a real disease, the approval of 3 different drugs by the FDA helped a lot because those companies had education programs that went along with their drug approvals, but over that period of time I think there has been a gradual acceptance that there is a number of drug therapies that can be helpful in fibromyalgia.
But we also have seen more and more literature suggesting that nondrug therapies—we’ve known forever that cognitive behavioral therapy and exercise were helpful treatments for fibromyalgia, but it’s really been in the last 5 to 10 years that it’s become clear that a much broader set of nondrug therapies are helpful, not just in fibromyalgia but in any chronic pain condition: things like mindfulness, yoga, tai chi, biofeedback chiropractic manipulation, acupuncture, acupressure. These are things that when I was trained 30 or so years ago, we were fairly dismissive of in the US healthcare systems that these things were not effective.
And now 30 years later the pendulum has swung away from the surgical procedures, the opioids, the injections that we overuse in the United States and we’re starting to more and more embrace the use of these nondrug therapies.
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Camlipixant May Benefit Patients With High-Burden RCC
June 25th 2025A phase 2a trial of camlipixant, a selective P2X3 receptor antagonist, found that while the drug did not significantly reduce cough frequency in the overall population with refractory chronic cough, it produced meaningful improvements in patients with a higher baseline cough burden.
Read More